<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2003-7-1-126-128</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВОПРОСЫ И ОТВЕТЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>QUESTIONS AND ANSWERS</subject></subj-group></article-categories><title-group><article-title>РЕНАЛЬНАЯ ДИСФУНКЦИЯ У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ ПРИ НАЗНАЧЕНИИ ИНГИБИТОРОВ АНГИОТЕНЗИН I-КОНВЕРТИРУЮЩЕГО ФЕРМЕНТА</article-title><trans-title-group xml:lang="en"><trans-title>RENAL DYSFUNCTION IN CHRONIC RENAL FAILURE PATIENTS AT ADMINISTRATION OF INHIBITORS OF ANGIOTENSIN I-CONVERTING ENZYME</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Есаян</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Essaian</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курс нефрологии и диализа факультета постдипломного образования</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Санкт-Петербургский государственный медицинский Университет им. акад. И.П.Павлова</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2003</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2003</year></pub-date><volume>7</volume><issue>1</issue><fpage>126</fpage><lpage>128</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Есаян А.М., 2003</copyright-statement><copyright-year>2003</copyright-year><copyright-holder xml:lang="ru">Есаян А.М.</copyright-holder><copyright-holder xml:lang="en">Essaian A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1008">https://journal.nephrolog.ru/jour/article/view/1008</self-uri><abstract><p>Ренальная дисфункция у пациентов с хронической почечной недостаточностью при назначении ингибиторов ангиотензин I-конвертирующего фермента.</p></abstract><trans-abstract xml:lang="en"><p>Renal dysfunction in chronic renal failure patients at administration of inhibitors of angiotensin I-converting enzyme.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая почечная недостаточность</kwd><kwd>артериальная гипертензия</kwd><kwd>ингибиторы АПФ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic renal failure</kwd><kwd>arterial hypertension</kwd><kwd>ACE inhibitors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446</mixed-citation><mixed-citation xml:lang="en">The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Navar LG Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol 1978; 234: F357-F370</mixed-citation><mixed-citation xml:lang="en">Navar LG Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol 1978; 234: F357-F370</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Schnermann J Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol 1998; 274: R263-R279</mixed-citation><mixed-citation xml:lang="en">Schnermann J Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol 1998; 274: R263-R279</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kitiyakara C., Guzman N Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 1998; 9: 133-142</mixed-citation><mixed-citation xml:lang="en">Kitiyakara C., Guzman N Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 1998; 9: 133-142</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ditscherlein G Renal histopathology in hypertensive diabetic patients. Hypertension 1985; 7: 11-29</mixed-citation><mixed-citation xml:lang="en">Ditscherlein G Renal histopathology in hypertensive diabetic patients. Hypertension 1985; 7: 11-29</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Strandgaard S Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976; 53: 720-727</mixed-citation><mixed-citation xml:lang="en">Strandgaard S Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976; 53: 720-727</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Remuzzi G, Bertani T Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456</mixed-citation><mixed-citation xml:lang="en">Remuzzi G, Bertani T Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chapman AB1 Gabow PA, Schrier RW. Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med 1991; 115:769-773</mixed-citation><mixed-citation xml:lang="en">Chapman AB1 Gabow PA, Schrier RW. Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med 1991; 115:769-773</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Seelig CB1 Maloley PA, Campbell JR. Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy. SouthMedJ 1990; 83: 1144-1148</mixed-citation><mixed-citation xml:lang="en">Seelig CB1 Maloley PA, Campbell JR. Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy. SouthMedJ 1990; 83: 1144-1148</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
